4//SEC Filing
Mainolfi Nello 4
Accession 0001193125-25-311504
CIK 0001815442other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:09 PM ET
Size
8.3 KB
Accession
0001193125-25-311504
Insider Transaction Report
Form 4
Mainolfi Nello
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-08$2.08/sh+100,000$208,000→ 760,482 total - Sale
Common Stock
2025-12-08$89.17/sh−100,000$8,917,000→ 660,482 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-08−100,000→ 305,559 totalExercise: $2.08Exp: 2029-11-13→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.
- [F2]The shares underlying this stock option are fully vested and exercisable.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821189
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:09 PM ET
- Size
- 8.3 KB